| Sign In to gain access to subscriptions and/or personal tools. |
Ineffectiveness of Ca2+-Antagonists Nicardipine and Diltiazem on Experimental Atherosclerosis in Cholesterol-fed RabbitsDepartment of Geriatrics, Nagoya University School of Medicine, Nagoya, Japan
Department of Geriatrics, Nagoya University School of Medicine, Nagoya, Japan
Department of Geriatrics, Nagoya University School of Medicine, Nagoya, Japan
Department of Geriatrics, Nagoya University School of Medicine, Nagoya, Japan
Department of Geriatrics, Nagoya University School of Medicine, Nagoya, Japan There is accumulating evidence that calcium metabolism plays an important role in the pathogenesis of atherosclerosis. The inhibitory effect of nifedipine, a Ca2-antagonist, on experimental atherosclerosis in cholesterol-fed rabbits has been reported, and we examined the anti-atherosclerotic action of nicardipine and diltiazem, similar Ca2+-antagonists, but no inhibitory action was observed. It is necessary to recognize the fact that the sensitivity of rabbits to an antiatherogenic diet shows great individual differences. For the purpose of preventing atherosclerosis due to the abnormality of lipid metabolism the use of Ca2+-antagonist is not warranted at the present stage.
Angiology, Vol. 35, No. 10,
622-627 (1984) This article has been cited by other articles:
|
|||||||||||||||||||||||||||

